CRISPR Therapeutics AG

CRSPNASDAQ · US

Holders

REDUCEDT+7
Kasinger James R.
CRISPR Therapeutics AG · NASDAQ
−1,990 sh · $119.5K
Filed 8 Oct 2026SEC Form 4view source
ACQUIREDT+7
Kasinger James R.
CRISPR Therapeutics AG · NASDAQ
+1,990 sh · $27.1K
Filed 8 Oct 2026SEC Form 4view source
ACQUIREDT+30
Kasinger James R.
CRISPR Therapeutics AG · NASDAQ
+10,400 sh · $141.6K
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Kasinger James R.
CRISPR Therapeutics AG · NASDAQ
−10,400 sh · $626.5K
Filed 24 Sept 2026SEC Form 4view source
REDUCEDT+30
Behbahani Ali
CRISPR Therapeutics AG · NASDAQ
−13,679 sh · $780.9K
Filed 21 Sept 2026SEC Form 4view source
ACQUIREDT+30
Behbahani Ali
CRISPR Therapeutics AG · NASDAQ
+60 sh
Filed 21 Sept 2026SEC Form 4view source
ACQUIREDT+30
Behbahani Ali
CRISPR Therapeutics AG · NASDAQ
+30,000 sh · $420.0K
Filed 21 Sept 2026SEC Form 4view source
ACQUIREDT+30
Behbahani Ali
CRISPR Therapeutics AG · NASDAQ
+15 sh
Filed 21 Sept 2026SEC Form 4view source
DISCLOSEDQuarterly
ARK Investment Management
CRISPR Therapeutics AG · NASDAQ
9,460,939 sh · $516.0M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDStale
ARK Investment Management
CRISPR Therapeutics AG · NASDAQ
11,313,623 sh · $538.2M
Filed 31 Mar 2026SEC 13Fview source